BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10553413)

  • 21. [A resected case of squamous cell carcinoma of the breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases].
    Hiramatsu K; Kato K; Hirata A; Matsuba H; Hara T; Ito T; Miyata T; Akagawa T; Kutsuna Y; Machiki Y; Fujioka S
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):443-6. PubMed ID: 17353640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous infusion of 5-fluorouracil with versus without low-dose, consecutive administration of cisplatin in advanced colorectal cancer. A prospective randomized phase II study.
    Nakata B; Sowa M; Tsuji A; Kamano T; Sasaki K; Fukunaga Y; Takahashi M; Tsujitani S; Mikami Y; Mitachi Y; Nishimura S; Araki H; Yamamitsu S; Hirakawa K; Tominaga S; Shirasaka T; Inokuchi K
    J Exp Clin Cancer Res; 2007 Mar; 26(1):51-60. PubMed ID: 17550132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F
    Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical modulation of 5-fluorouracil with interferon alpha/beta and gamma on murine renal cell carcinoma.
    Ishii T; Marumo K
    Int J Urol; 2004 Nov; 11(11):993-1000. PubMed ID: 15509204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combined chemotherapy with low-dose cisplatin, tegafur and uracil for head and neck squamous cell carcinomas].
    Nishino H; Abe K; Ishikawa K; Kanazawa T; Tanaka H; Miyata M; Kitamura K; Morita M
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1617-21. PubMed ID: 10553420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study.
    Hussain MH; Glass TR; Forman J; Sakr W; Smith DC; Al-Sarraf M; Jones J; Balcerzak SP; Crawford ED; Grossman HB
    J Urol; 2001 Jan; 165(1):56-60; discussion 60-1. PubMed ID: 11125363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma.
    Nakazawa M; Ohnishi T; Ohmae M; Chisoku H; Yui S; Iwai S; Sumi T; Fukuda Y; Kishino M; Yura Y
    Int J Clin Pharmacol Res; 2005; 25(3):115-22. PubMed ID: 16366419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
    de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party.
    van Herpen CM; Jansen RL; Kruit WH; Hoekman K; Groenewegen G; Osanto S; De Mulder PH
    Br J Cancer; 2000 Feb; 82(4):772-6. PubMed ID: 10732744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
    J Gastroenterol; 2005 Jan; 40(1):70-8. PubMed ID: 15692792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on 5-FU concentration in serum and bladder tumor tissue after oral administration of UFT].
    Takayama H; Konami T; Konishi T; Pak K; Tomoyoshi T
    Hinyokika Kiyo; 1986 Oct; 32(10):1449-53. PubMed ID: 3105272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A trial of continuous and biweekly low-dose cisplatin and 5-FU with UFT chemotherapy for esophageal cancer].
    Takamura H; Sasaki S; Hasebe K; Urade M; Yagi M
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1809-15. PubMed ID: 12402435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemotherapy of advanced genitourinary carcinoma with cis-diamminedichloroplatinum].
    Uchida T; Kobayashi K; Arakawa T; Omata T; Li K; Ikeda S; Endo T; Ishibashi A; Koshiba K
    Hinyokika Kiyo; 1984 Sep; 30(9):1173-83. PubMed ID: 6084421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effective and low toxicity chemoradiotherapy for distant metastatic esophageal cancer].
    Ohsawa H; Aiba K; Sugiyama K; Mizunuma N; Takahashi S; Ito Y; Horikoshi N
    Gan To Kagaku Ryoho; 1999 Dec; 26(14):2229-32. PubMed ID: 10635309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combination therapy of a novel oral fluorouracil derivative TS-1 with low-dose cisplatin for recurrent and very advanced gastric cancer].
    Nakata B; Hirakawa K
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1962-8. PubMed ID: 15570921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence-dependence of cisplatin and 5-fluorouracil in advanced and recurrent gastric cancer.
    Koizumi W; Kurihara M; Hasegawa K; Chonan A; Kubo Y; Maekawa R; Iwasaki R; Sasai T; Fukuyama Y; Ishikawa K; Miyoshi K; Yasutake K; Hayakawa M
    Oncol Rep; 2004 Sep; 12(3):557-61. PubMed ID: 15289837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of advanced gastric cancer complicated with liver metastases responding remarkably to combined chemotherapy with 5-fluorouracil and low-dose cisplatin, with UFT and low-dose cisplatin for maintenance on an outpatient basis].
    Niiya F; Ikeda S; Nagata S; Iwamoto M; Shirouzu K
    Gan To Kagaku Ryoho; 2001 Mar; 28(3):391-4. PubMed ID: 11265411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The progress of hepatic arterial infusion chemotherapy for hepatocellular carcinoma].
    Noda T; Nagano H; Wada H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Ohsuga K; Kim T; Tomoda K; Nakamura H; Monden M
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1221-5. PubMed ID: 16969014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.